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Digital gangrene and pneumatosis intestinalis associated with
calciphylaxis
Qingwen Kawaji, MSc,a Erik Brian Eller, MD,b Jerry Yee, MD,c and Judith C. Lin, MD, MBA,a Detroit, Mich

ABSTRACT
Reports of calciphylaxis or calciﬁc uremic arteriolopathy associated with acral and gastrointestinal involvement are rare.
We describe a 36-year-old white woman with end-stage renal disease on hemodialysis after failed kidney and pancreas
transplantation who developed dry gangrene of bilateral digits, osteomyelitis, and small bowel ischemia within several
months of each presentation. She had multiple débridements of a septic right ankle. Computed tomography angiography showed severe vascular calciﬁcation and pneumatosis intestinalis. She underwent intestinal resection for
gangrenous small bowel. A multidisciplinary approach with aggressive medical and surgical management may improve
survival. Our case and the literature conﬁrm the high morbidity of patients with calciphylaxis and vascular complications.
Careful follow-up remains necessary for diagnosis and management to prevent complication, infection, and
death. (J Vasc Surg Cases and Innovative Techniques 2018;4:133-5.)

CASE REPORT

mesenteric vessels. Signiﬁcant laboratory studies showed low

A 36-year-old woman with history of type 1 diabetes mellitus,

glomerular ﬁltration rate of 11 mL/min/1.73 m2, elevated parathy-

end-stage renal disease on hemodialysis, hypertension, osteo-

roid level of 28 pg/mL, and high phosphorus level of 5.6 mg/dL.

myelitis, and pancreas and kidney transplantation, with

The diagnosis of calciphylaxis was determined on the basis of

subsequent failure of the kidney transplant, underwent right
triple arthrodesis with a right midtarsal arthrodesis and an Achil-

clinical presentation.
Two months later, the patient presented to the emergency

les tendon lengthening in 2014. Six months before her last

department with a 2-day history of diffuse abdominal pain asso-

hospitalization, she developed a septic right ankle and under-

ciated with nausea, vomiting, nonbloody diarrhea, fever, and

went removal of the hardware for a Charcot midfoot. She had

chills. CT of the abdomen revealed extensive small bowel pneu-

a 6-week course of intravenous ertapenem for Streptococcus

matosis involving multiple bowel loops, suggestive of ischemic

mitis and Klebsiella pneumoniae. She underwent placement
of a right ankle spatial frame for loss of bone and antibiotic
beads for persistent infection from Klebsiella oxytoca and
Enterococcus faecalis (Fig 1). Additional wound culture showed
Stenotrophomonas (Xanthomonas) maltophilia. She declined
amputation of her right foot.
The patient developed a 3-month history of intermittent paresthesia, worsening pallor, and eventual dry gangrene of the
ﬁngers (Fig 2). The vascular surgery service was consulted for
evaluation of painful, gangrenous hands and left foot. Anklebrachial index showed incompressible vessels with absent
perfusion of the digits and toes. Computed tomography (CT)
angiography (Fig 3) showed circumferential calciﬁed atherosclerotic disease of the ulnar, radial, and interosseous arteries and

causes. The superior mesenteric artery demonstrated dense,
circumferential atherosclerosis with circumferential calciﬁcation
at the distal branches. The patient underwent resection of
130 cm of necrotic small bowel and second-look laparotomy.
Pathologic examination showed transmural ischemic necrosis
with ulceration, perforation, and acute peritonitis. She was
discharged home 2 weeks later.
Six months after her initial presentation of septic arthritis,
3 months after digital gangrene, and 2 months after ischemic
bowel, the patient developed leukocytosis, hypotension, and
decubitus ulcer. She was readmitted for infection of the right
foot, treated with antibiotics, and discharged 2 weeks before
her death at home on December 30, 2017. Consent for publication was obtained from the patient before her death.
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Also known as calciﬁc uremic arteriolopathy, calciphylaxis was ﬁrst characterized by Selye et al1 in 1961 as a
hypersensitivity reaction in rodents resulting in calciﬁcation of skin and skeletal muscles. It is a devastating
disease with an estimated prevalence of 4.1% in hemodialysis patients and mortality of 60% within 1 year due to
infections.2,3 The mechanism of arterial calciﬁcation is a
dynamic and active process that shares common
grounds with normal bone mineralization.4 Under the
inﬂuence of b-glycerophosphate, smooth muscle cells
can undergo osteoblastic differentiation, resulting in a
favorable environment for mineralization.4 Calciﬁcation
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Fig 1. Placement of right ankle spatial frame for loss of
bone and heel gangrene.

Fig 2. Dry gangrene of multiple ﬁngers.

occurs in the intimal layer, leading to atherosclerotic
plaque and a decreased luminal area, and in the medial
layer, resulting in loss of arterial compliance.5 Histologic
features include small- and medium-vessel medial calciﬁcation with intimal calcium deposits associated with
dermal angioplasia and thrombosis. There is no histologic difference between patients with and patients without
chronic kidney disease.4
Common presentation of calciphylaxis includes painful
and nonhealing wounds that can result in black eschar
and secondary superinfection.6 Most commonly, these
lesions occur in adipose-rich areas, such as trunk,
buttocks, and thighs, although acral and penile involvement has also been reported.7-9 Ocular, cardiovascular,
pulmonary, and gastrointestinal system complications
are extremely rare, with fewer than 10 reported cases of
gastrointestinal involvement in calciphylaxis.7,8,10-13 Risk
factors for calciphylaxis include hyperparathyroidism,
elevated calcium-phosphorus product, chronic kidney
disease, diabetes, female sex, warfarin use, and obesity.9
Diagnosis of calciphylaxis is clinically supported by skin
biopsy as the “gold standard.” However, normal ﬁndings
on skin biopsy do not rule out calciphylaxis because

Fig 3. Computed tomography (CT) angiography showed
circumferential calciﬁed atherosclerotic disease of arteries
in the upper extremities and mesenteric vessels.

only 18% of 56 biopsy specimens from conﬁrmed
patients showed classic features of calciﬁcation of the
arterioles.2 Hayashi6 proposed the use of histopathologic
ﬁndings for calciphylaxis only if three of the clinical ﬁndings are not present: chronic hemodialysis or glomerular
ﬁltration rate <15 mL/min/1.73 m2; more than two painful
and nontreatable skin ulcers; and ulcers on trunk,
extremities, or penis.
The high mortality rate of calciphylaxis is most often
associated with infection of nonhealing wounds leading
to sepsis, with 1-year survival <50% and 2-year
survival <20%.2 Gastrointestinal involvement of calciphylaxis is extremely rare with grim outcome.7,8,10-13 A case
report described a 63-year-old woman who presented
with skin lesions of bilateral calves, single-digit discoloration of the left hand, and abdominal pain, with CT
conﬁrming colonic perforation.12 Another case report
described a 66-year-old woman with black necrotic
eschar on bilateral lower extremities, lower gastrointestinal bleed, and rectal necrosis.13 The patients of both
cases died of sepsis and multiorgan failure. Although
skin biopsy may conﬁrm diagnosis of calciphylaxis, we
advise clinicians to use caution regarding skin biopsy
and invasive treatments because of poor healing and
increased risk of sepsis.6
Current mainstays of treatment are mostly supportive,
including pain control, wound care, intravenous sodium
thiosulfate, correction of calcium and phosphorus levels,
bisphosphonates, vitamin K, and full-intensity anticoagulation.2 Patecki et al9 recommended bone biopsy in
patients with calciphylaxis to dictate therapy after determination of the level of bone turnover. The beneﬁt of kidney transplantation in calciphylaxis remains unclear, and
diverging results after renal transplantation have been
reported.2 An observational study proposed that intralesional sodium thiosulfate injections rather than
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intravenous infusions may be an effective treatment of
skin lesions due to calciphylaxis; however, this recommendation was based on four patients, and a case report
showed that needle injections led to abscess formation
and worsening of skin lesions.14 Hyperbaric oxygen therapy (HBOT) is associated with better wound healing
and extended survival time in >50% of patients with an
average of 44 treatments; diabetes was the only factor
that signiﬁcantly inﬂuenced wound healing and mortality.15 Use of sodium thiosulfate with HBOT has also been
suggested to have a synergistic effect, but concrete data
are needed for recommendation.16 The role of revascularization for wound healing in calciphylaxis is insufﬁciently
studied with no deﬁnitive recommendations. Furthermore, vascular procedures are a negative determinant
of survival in patients with calciphylaxis.17
Multiple studies suggest that treatment of calciphylaxis
is multimodal, and early initiation of such therapies is
instrumental in achieving the best patient outcome.2,6,16
Finally, because of the high mortality and morbidity associated with calciphylaxis, it is important to initiate early
conversations of disease prognosis and approach to therapy with patients and their families so that their priorities
can be factored in when management is being planned.2
Finally, it is important to address end-of-life issues with
such patients because of the high mortality and
morbidity associated with calciphylaxis.

CONCLUSIONS
This patient has multiple risk factors and clinical
presentation for calciphylaxis. Noninvasive arterial
studies and CT angiography demonstrating incompressible vessels and vascular calciﬁcations further solidify the
diagnosis of calciﬁc uremic arteriolopathy. HBOT and
sodium thiosulfate may be considered viable therapies.
A multidisciplinary approach with aggressive medical
and surgical management may improve survival. Our
case and the literature conﬁrm the high morbidity of
patients with calciphylaxis and vascular complications.
Careful follow-up remains necessary for diagnosis
and management to prevent complication, infection,
and death.
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